IMPORTANCE Inherited retinal dystrophies (IRDs) are a group of retinal degenerative diseases presenting genetic and clinical heterogeneities, which have challenged the genetic and clinical diagnoses of IRDs. Genetic evaluations of patients with IRD might result in better clinical assessments and better management of patients.
tionary night blindness, 4 Leber congenital amaurosis, 5 Bietti crystalline dystrophy, 6 Stargardt disease, 7 Best vitelliform macular dystrophy, 8 and various other comparatively rare retinal degenerations. Typical systemic diseases that may be accompanied with IRD may include Usher syndrome (OMIM 276900) or Bardet-Biedl syndrome (OMIM 209900), as well as others. Clinical diagnoses of IRDs can sometimes be challenged by phenotypic overlaps among distinct diseases and among certain conditions, such as a young child with a less severe clinical condition or a retinal disease that is possibly a part of a syndrome. In such situations, molecular genetic testing could be useful to address the clinical ambiguity in diagnosis. Inherited retinal dystrophy can be inherited via all 3 methods of Mendelian inheritance (ie autosomal dominant, recessive, and X-linked patterns). Digenic, mitochondrial, and incomplete dominant forms have also been reported. 1, 9, 10 To date, 261 loci (including 221 identified genes) have been implicated in the etiology of IRDs (see the Retinal Information Network [RetNet] at https://sph.uth.edu/retnet/), representing its great genetic heterogeneity. Traditional approaches to the detection of mutations have their limitations, resulting in low diagnostic rates. However, targeted next-generation sequencing (NGS) enables parallel sequencing of a panel of numerous candidate genes and has been proved to be an efficient tool for the molecular diagnosis of various IRDs 11 and of autosomal recessive RP.
12
To develop an effective genetic diagnostic tool for IRDs, we have previously used a targeted NGS approach, by which we identified disease-causing mutations in multiple types of IRDs.
11,13,14 Herein, we have further applied this approach in the investigation of a cohort of 20 Chinese families with autosomal recessive IRD.
Methods

Participants and Clinical Investigations
Our study conformed to the tenets of the Declaration of Helsinki and was prospectively reviewed and approved by the local institutional review boards. Written informed consent was obtained from all participants or their legal guardians. A cohort of 20 unrelated Chinese families, including 33 patients affected with IRD and 61 unaffected family members, were recruited from multiple hospitals in China (eTable 1 in the Supplement). Family histories and personal medical records were carefully checked and reviewed. All of the participants underwent detailed ophthalmic examinations at the beginning of the study and systemic examinations when necessary. The data obtained from these ophthalmic examinations included best-corrected visual acuity, results of a slitlamp examination, intraocular pressure, results of a funduscopic examination, visual field, and electroretinograms. Optical coherence tomography was performed for patients with macular degeneration. For patient RH13-II:1, a 3-T magnetic resonance scanner (Magnetom Trio; Siemens Medical Solutions) with a transmit-receive extremity coil was used for an examination of the spinal cord. In addition, 150 unrelated Chinese controls without IRD or other ocular diseases were also included. Samples of venous blood (5 mL) were obtained from each participant for genomic DNA isolation, which was performed using a QIAmp DNA Mini Blood Kit (Qiagen).
Targeted NGS
A targeted gene approach was completed using 2 previously described capture arrays (from Roche NimbleGen). Microarray 1 was designed to capture the targeted region of 179 IRD-related genes and 10 candidate genes. 11 Microarray 2 was designed to capture the coding sequence region of 316 genes related to inherited ocular diseases. 15 Sequence capture, enrichment, elution, and NGS were conducted as detailed previously. 16 For bioinformatics analyses, the results of Sanger sequencing, in silico analyses, and the results of reverse transcription-polymerase chain reaction, see the eAppendix in the Supplement.
Results
Targeted NGS Approach
Here, we only focus on the results of 11 of the 20 families investigated because putative disease-causing mutations were identified in the 11 families. Detailed clinical data on the 11 families are summarized in Table 1 and Table 2 , whereas the clinical details of family pedigrees and the genetic findings of the other 9 families are presented in eFigure 1 and eTables 2 and 3 in the Supplement. One or 2 family members from each family were selected for NGS, and the results of NGS are detailed in eTable 4 in the Supplement. In brief, a total of 26 650 variants were initially detected by targeted NGS in the 11 families. Of all tested samples, the mean call rate of the targeted region was about 99.8%, and the mean depth was about 91.3-fold. A total of 17 homozygous or compound heterozygous variants in the 11 families passed the filtration process, of which 12 were novel and 5 were previously reported mutations ( Table 3) . Those novel variants were absent in 150 unrelated Chinese controls. The potential pathogenicity of those novel putative mutations was evaluated by multiple in silico programs and is summarized in Table 3 . Figure 1 ). This patient was reported to have central visual defects since the age of 5 years, and her best-corrected visual acuity was 20/100 for the right eye and 20/400 for the left eye at her last visit to our hospital. Macular degeneration was revealed in fundus photographs and optical coherence tomographic images ( Figure 1B and C). Reduced photopic and scotopic electroretinographic responses were observed ( Figure 1D ). Visual field constriction and central scotoma were also indicated ( Figure 1E ). RH18 with typical RP (Figure 2A and B; Figure 3A ). Conservational analysis also proved the high level of conservation of residue H331 in multiple orthologous protein sequences ( Figure 2C ). Clinical evaluations were presented in Figure 3A and B and Tables 1 and  2 , and waxy optic discs and attenuated vessels are present in all patients. Crystal deposits are present in patients RH6-II:1, RH6-II:2, and RH12-II:3, whereas bone spicule-like pigments are revealed in patients RH12-II:3, RH18-II:1, RH18-II:2, and RH18-II: 3. Macular atrophy was detected on the optical coherence tomographic images of patient RH6-II:1. An interesting finding is that intensive bone spicule-like pigments were observed in the fundus photographs of patient RH12-II:3, whereas crystal deposits were only found in the macular region ( Figure 3A ).
Novel Insights Into the Clinical Assessments in 4 Families
CYP4V2
Finalizing the Clinical Diagnoses in 4 Families
Identification of BBS2 Mutation in Family RH1 A previously reported homozygous missense variant in BBS2 (p.R413* [CM033336]) was identified in family RH1 with BardetBiedl syndrome ( Figure 4A ). The 2 siblings, RH1-V:1 and RH1-V:2, were still in their teens when they first were referred to our clinic for having poor night vision and a constricted visual field.
Results of an ophthalmic examination revealed typical RP presentations ( Figure 5 ). Other than ophthalmic abnormities, results of systemic examinations revealed polydactylism and mild cognitive impairment in both patients. The affected sister showed no signs of menophania at her visit when she was 18 years of age. Each member of this family thus received a diagnosis of BardetBiedl syndrome based on genetic and clinical findings.
Identification of PROM1 Mutations in Family RH9
A novel homozygous frameshift mutation in PROM1 (p.K549Qfs*2) was identified in patients from family RH9 ( Figure 4A ). PROM1 mutations have been reported to be the cause of recessive RP with macular degeneration, dominant Stargardt disease-like macular dystrophy, dominant cone dystrophy, and dominant CRD (RetNet). All 3 patients from family RH9 reported having night blindness since early childhood, and at their last visit, each patient had central vision that was severely impaired owing to severe macular degeneration ( Figure 5 ; Tables 1 and 2 ). Presentations of RP and macular degeneration were indicated in the fundus photographs of patients from this family. Therefore, based on the genetic and clinical findings, we finalized the clinical diagnosis to autosomal recessive RP with macular degeneration for this family. 
Identification of ALMS1 Mutations in Family RH10
Novel biallelic ALMS1 mutations p.[S1218*]; [Y1533*] were identified as disease causing for family RH10 ( Figure 4A ; Tables 1-3) . Patient RH10-II:1 was reported to have nystagmus and photophobia since 5 months of age. His visual acuity began to decrease rapidly early in the second decade of his life. At his last visit to our clinic, he was 18 years of age when his bestcorrected visual acuity was light perception for both eyes. Fundus photographs and electroretinographic responses indicated a typical presentation of CRD in this patient ( Figure 5 ). Because ALMS1 mutations have been reported to cause Alström syndrome, his medical records were further examined, and more biochemical tests performed. Detailed systematic examinations revealed sensorineural hearing loss, early-onset type 2 diabetes mellitus, obesity, dilated cardiomyopathy, and hepatic dysfunction in this patient, which fully met the diagnostic criteria for Alström syndrome. Therefore, the genetic findings for this patient helped to define the clinical diagnosis of Alström syndrome in this case.
Identification of FLVCR1 Mutations in Family RH13
Patient RH13-II:1 had poor night vision since early childhood, followed by a rapid decrease in her visual field and central vision ( Figure 6A ; Tables 1 and 2 ). Ophthalmic evaluations demonstrated typical RP phenotypes with macular edema in her right eye ( Figure 6B and C). Complex neural phenotypes were also noted in patient RH13-II:1, including mild ataxia since childhood, attenuation of deep tendon reflexes, and superficial sensations. Magnetic resonance imaging revealed a mild enlargement of the central canal from C3 to T8 vertebral levels. Herniated disks were indicated in C4/5, C5/6, and C6/7, and magnetic resonance imaging at C4/5 revealed the centrally herniated disk material and the narrowing of the spinal canal ( Figure 6E-G) . By use of targeted NGS, we identified novel biallelic mutations in the FLVCR1 gene in patient RH13-II:1, including the paternal inherited splice site mutation c.883+6T>C and the maternal inherited missense variation p.G384R. The missense variation was predicted to be deleterious by all in silico programs, and the residue G384 was absolutely conserved through evolution ( Figure 1A and D) . Reverse transcription-polymerase chain reaction was then performed to determine the effect of the paternal inherited allele. Reverse transcription-polymerase chain reaction products were separated by agarose gel electrophoresis, and 4 bands were observed in patient RH13-II:1 and her unaffected father RH13-I:1, who carried the same allele (eFigure 2A in the Supplement). Sequencing of the product revealed that this splice site mutation would cause aberrant splicing of the FLVCR1 gene by generating a mutant complementary DNA fragment inserted with a 127-base pair (bp) fragment from intron 2 beginning at c.883+524 (eFigure 2B in the Supplement). FLVCR1 mutations have been implicated in the disease etiology of autosomal recessive posterior column ataxia with RP (PCARP). [25] [26] [27] Therefore, this patient received a diagnosis of PCARP.
Putative Mutations and Clinical Manifestations in Another 3 Families
The novel homozygous missense mutation in CRB1 (p.C606R) was identified in patient RH17-IV:3 with RP, whose parents were first-degree cousins. Typical RP presentations on fundus photographs, including waxy pallor of optic discs, attenuated ves- (Figure 4A ). ABCA4 mutations have been found to cause recessive Stargardt disease, recessive macular dystrophy, recessive RP, recessive fundus flavimaculatus, and recessive CRD, whereas CNGA1 mutations were only implicated in the disease etiology of RP (RetNet). Therefore, the correlations between the affected genes and the phenotypes observed in the 2 families were previously established.
Discussion
We have previously evaluated the efficiency of targeted NGS in families with IRD, which is mainly in autosomal dominant trait or sporadic cases. 11 In the present study, we focused on the mutation analyses for a cohort of 20 Chinese families with autosomal recessive IRD. A detection rate of 55% (11 of 20 families) is achieved in this cohort, similar to that in our previous study (56%) 11 and a bit higher than that in other Chinese cohorts with autosomal recessive IRD. 12,28,29 Seventeen disease-causing mutations have been identified in the 11 families investigated, among which 12 are novel to our knowledge. Thus, our study extends the spectrum of IRD disease-causing mutations. Mutations in RP1 have been reported to cause RP, accounting for 5.5% of the autosomal dominant form and 1% of the recessive form. 30 The 
HET indicates heterozygous; OCT, optical coherence tomographic; MRI, magnetic resonance imaging; and MU, mutation. The white arrowheads indicate bone spicular pigmentation. The yellow arrowheads indicate enlargement of the central canal from C3 to T8 vertebral levels.
RP1 mutations in patients with CRD, suggesting a potential relationship between RP1 defects and the pathogenesis of CRD. Bietti crystalline dystrophy, also referred to as Bietti crystalline corneoretinal dystrophy, is inherited in an autosomal recessive fashion with only 1 disease-causing gene, CYP4V2.
38
Patients with Bietti crystalline dystrophy often present with corneal crystals, yellow deposits in the retina, and progressive retinal and choroidal atrophy. 39 Other than Bietti crystal- 43 Thus, we hypothesize that mutant hFLVCR with p.Gly384Arg would also misfold in the endoplasmic reticulum, partially degrade in lysosomes, lose heme export activity, cause intracellular accumulation, and lead to apoptosis. 43 Furthermore, the splice site mutation, c.883+6T>C, is predicted to generate a splice donor site and a splice receptor site within the intronic sequence between exons 2 and 3, thus leading to the insertion of a 127-bp fragment. This insertion would probably generate an altered protein with an irregular function or cause messenger RNA decay. Of note, further investigation of this inserted fragment has revealed its existence as the second exon of the coding sequence of another FLVCR1 transcript (ENST00000579295); however, no protein product has been annotated for this transcript. Because the specific mechanism underlying the association between FLVCR1 gene deficits and symptoms of PCARP is still unclear, we hypothesize a potential linkage between hFLVCR protein dysfunction and neurological problems. Therefore, our study demonstrates that the targeted NGS approach might help to generate a molecular diagnosis for autosomal recessive IRDs. However, this approach also has limitations. A mean mismatch rate of 0.234% was reached in our study, indicating the potential existence of false-positive or falsenegative variants. In addition, deep intronic variations and copy number variations could not be detected by this approach. No disease-causing mutations were identified in the remaining 9 families. These 9 families may carry mutations in unknown loci, deep intronic mutations, or copy number variations, all of which are not detectable by our targeted NGS approach.
Conclusions
In conclusion, by means of targeted NGS, we have revealed 15 disease-causing mutations, including 12 novel mutations found in 11 of 20 Chinese families with autosomal recessive IRD. Our finding reaches a detection rate of 55% in the investigated cohort, which demonstrates the efficiency of targeted NGS in analyzing the etiology for autosomal recessive IRDs. In addition, based on all our findings, we believe that the genetic evaluations would help with clinical assessments.
